Main menu

London Calling 2023: Nanopore sequencing of ctDNA — better than short read!

Get startedSubscribe
Return to Resources

In this talk I will discuss the potential applications of nanopore ctDNA sequencing in developing a pan-cancer assay for detection and screening. Through this, I will demonstrate data that shows the detection of MDM2 copy number in sarcoma samples as well as very low input VAF samples. I will also give an overview of some of the technical challenges that have to be overcome with nanopore sequencing of ctDNA

Authors: Andrew Beggs
Learn more about cancer research and sequencing
  • Published on: May 19 2023

入门指南

购买 MinION 启动包 Nanopore 商城 测序服务提供商 全球代理商

纳米孔技术

订阅 Nanopore 更新 资源库及发表刊物 什么是 Nanopore 社区

关于 Oxford Nanopore

新闻 公司历程 可持续发展 领导团队 媒体资源和联系方式 投资者 合作者 在 Oxford Nanopore 工作 职位空缺 商业信息 BSI 27001 accreditationBSI 90001 accreditationBSI mark of trust

沪ICP备20017565号 © 2008 - 2023 Oxford Nanopore Technologies plc。版权所有。注册办公室：Gosling Building, Edmund Halley Road, Oxford Science Park, OX4 4DQ, UK（英国）{'|'} 注册号 05386273 {'|'} 增值税号 336942382。Oxford Nanopore Technologies、风轮图标、EPI2ME、Flongle、GridION、Metrichor、MinION、MinIT、MinKNOW、Plongle、 PromethION、SmidgION、Ubik 和 VolTRAX 是 Oxford Nanopore Technologies plc 在 不同国家的注册商标。Oxford Nanopore Technologies 产品并非旨在用于健康评估或 诊断、治疗、缓解、治愈或预防任何疾病或状况。

Chinese flag